Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A D'Alessio

Showing results (1-10 of 182) with videos related to

Pageof 19
Sort By:
Diabetes|January 21, 2025
Diabetes Spotlight: A New Addition to the JournalDavid A D'Alessio
Transactions of the American Clinical and Climatological Association|August 7, 2025
REVISITING GLUCAGON ACTION IN DIABETES: IS IT ALL BAD?David A D'Alessio
Endocrinology|July 26, 2011
What if gut hormones aren't really hormones: DPP-4 inhibition and local action of GLP-1 in the gastrointestinal tractDavid A D'Alessio
Diabetes|July 1, 2010
Taking aim at islet hormones with GLP-1: is insulin or glucagon the better target?David A D'Alessio
Diabetes|February 20, 2025
Development of the Insulin Radioimmunoassay, the Watershed Moment in Diabetes Research: Revisiting 1960 Diabetes Classics by Berson and YalowDavid A D'Alessio
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|August 29, 2016
Mechanisms of surgical control of type 2 diabetes: GLP-1 is the key factor-MaybeMarzieh Salehi, David A D'Alessio
The Journal of Clinical Endocrinology and Metabolism|May 10, 2022
Slow and Steady Wins the Race: 25 Years Developing the GLP-1 Receptor as an Effective Target for Weight LossNitya Kumar, David A D'Alessio
Diabetes|November 20, 2023
Glucagon as the First Incretin: Objects (in the Rearview Mirror) Are Closer Than They AppearDavid A D'Alessio, Vincent Marks
Cleveland Clinic Journal of Medicine|April 14, 2006
New therapies for type 2 diabetes based on glucagon-like peptide 1Marzieh Salehi, David A D'Alessio
Reviews in Endocrine & Metabolic Disorders|June 22, 2014
Effects of glucagon like peptide-1 to mediate glycemic effects of weight loss surgeryMarzieh Salehi, David A D'Alessio
Pageof 19

Showing results (1-10 of 182) with videos related to

Sort By:
Pageof 19
Diabetes|January 21, 2025
Diabetes Spotlight: A New Addition to the JournalDavid A D'Alessio
Transactions of the American Clinical and Climatological Association|August 7, 2025
REVISITING GLUCAGON ACTION IN DIABETES: IS IT ALL BAD?David A D'Alessio
Endocrinology|July 26, 2011
What if gut hormones aren't really hormones: DPP-4 inhibition and local action of GLP-1 in the gastrointestinal tractDavid A D'Alessio
Diabetes|July 1, 2010
Taking aim at islet hormones with GLP-1: is insulin or glucagon the better target?David A D'Alessio
Diabetes|February 20, 2025
Development of the Insulin Radioimmunoassay, the Watershed Moment in Diabetes Research: Revisiting 1960 Diabetes Classics by Berson and YalowDavid A D'Alessio
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|August 29, 2016
Mechanisms of surgical control of type 2 diabetes: GLP-1 is the key factor-MaybeMarzieh Salehi, David A D'Alessio
The Journal of Clinical Endocrinology and Metabolism|May 10, 2022
Slow and Steady Wins the Race: 25 Years Developing the GLP-1 Receptor as an Effective Target for Weight LossNitya Kumar, David A D'Alessio
Diabetes|November 20, 2023
Glucagon as the First Incretin: Objects (in the Rearview Mirror) Are Closer Than They AppearDavid A D'Alessio, Vincent Marks
Cleveland Clinic Journal of Medicine|April 14, 2006
New therapies for type 2 diabetes based on glucagon-like peptide 1Marzieh Salehi, David A D'Alessio
Reviews in Endocrine & Metabolic Disorders|June 22, 2014
Effects of glucagon like peptide-1 to mediate glycemic effects of weight loss surgeryMarzieh Salehi, David A D'Alessio
Pageof 19